Cargando…

Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study

AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity levels and incident diabetic retinopathy and change in retinopathy grade. METHODS: This was a cohort study of diabetic participants with serum collected at base...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Moneeza K., Kennedy, Gwen, Carr, Fiona, Doney, Alexander S. F., Pearson, Ewan R., Morris, Andrew D., Johnson, Toby, McLaughlin, Megan M., Williams, Rachel E., Palmer, Colin N. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447502/
https://www.ncbi.nlm.nih.gov/pubmed/29623345
http://dx.doi.org/10.1007/s00125-018-4601-7
_version_ 1783408504888885248
author Siddiqui, Moneeza K.
Kennedy, Gwen
Carr, Fiona
Doney, Alexander S. F.
Pearson, Ewan R.
Morris, Andrew D.
Johnson, Toby
McLaughlin, Megan M.
Williams, Rachel E.
Palmer, Colin N. A.
author_facet Siddiqui, Moneeza K.
Kennedy, Gwen
Carr, Fiona
Doney, Alexander S. F.
Pearson, Ewan R.
Morris, Andrew D.
Johnson, Toby
McLaughlin, Megan M.
Williams, Rachel E.
Palmer, Colin N. A.
author_sort Siddiqui, Moneeza K.
collection PubMed
description AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity levels and incident diabetic retinopathy and change in retinopathy grade. METHODS: This was a cohort study of diabetic participants with serum collected at baseline and routinely collected diabetic retinal screening data. Participants with type 2 diabetes from the GoDARTS (Genetics of Diabetes Audit and Research in Tayside Scotland) cohort were used. This cohort is composed of individuals of white Scottish ancestry from the Tayside region of Scotland. Survival analysis accounting for informative censoring by modelling death as a competing risk was performed for the development of incident diabetic retinopathy from a disease-free state in a 3 year follow-up period (n = 1364) by stratified Lp-PLA(2) activity levels (in quartiles). The same analysis was performed for transitions to more severe grades. RESULTS: The hazard of developing incident diabetic retinopathy was 2.08 times higher (95% CI 1.64, 2.63) for the highest quartile of Lp-PLA(2) activity compared with the lowest. Higher Lp-PLA(2) activity levels were associated with a significantly increased risk for transitions to all grades. The hazards of developing observable (or more severe) and referable (or more severe) retinopathy were 2.82 (95% CI 1.71, 4.65) and 1.87 (95% CI 1.26, 2.77) times higher for the highest quartile of Lp-PLA(2) activity compared with the lowest, respectively. CONCLUSIONS/INTERPRETATION: Higher Lp-PLA(2) levels are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy. These associations are independent of calculated LDL-cholesterol and other traditional risk factors. Further, this biomarker study shows that the association is temporally sensitive to the proximity of the event to measurement of Lp-PLA(2.) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-018-4601-7) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6447502
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64475022019-04-17 Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study Siddiqui, Moneeza K. Kennedy, Gwen Carr, Fiona Doney, Alexander S. F. Pearson, Ewan R. Morris, Andrew D. Johnson, Toby McLaughlin, Megan M. Williams, Rachel E. Palmer, Colin N. A. Diabetologia Article AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity levels and incident diabetic retinopathy and change in retinopathy grade. METHODS: This was a cohort study of diabetic participants with serum collected at baseline and routinely collected diabetic retinal screening data. Participants with type 2 diabetes from the GoDARTS (Genetics of Diabetes Audit and Research in Tayside Scotland) cohort were used. This cohort is composed of individuals of white Scottish ancestry from the Tayside region of Scotland. Survival analysis accounting for informative censoring by modelling death as a competing risk was performed for the development of incident diabetic retinopathy from a disease-free state in a 3 year follow-up period (n = 1364) by stratified Lp-PLA(2) activity levels (in quartiles). The same analysis was performed for transitions to more severe grades. RESULTS: The hazard of developing incident diabetic retinopathy was 2.08 times higher (95% CI 1.64, 2.63) for the highest quartile of Lp-PLA(2) activity compared with the lowest. Higher Lp-PLA(2) activity levels were associated with a significantly increased risk for transitions to all grades. The hazards of developing observable (or more severe) and referable (or more severe) retinopathy were 2.82 (95% CI 1.71, 4.65) and 1.87 (95% CI 1.26, 2.77) times higher for the highest quartile of Lp-PLA(2) activity compared with the lowest, respectively. CONCLUSIONS/INTERPRETATION: Higher Lp-PLA(2) levels are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy. These associations are independent of calculated LDL-cholesterol and other traditional risk factors. Further, this biomarker study shows that the association is temporally sensitive to the proximity of the event to measurement of Lp-PLA(2.) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-018-4601-7) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2018-04-06 2018 /pmc/articles/PMC6447502/ /pubmed/29623345 http://dx.doi.org/10.1007/s00125-018-4601-7 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Siddiqui, Moneeza K.
Kennedy, Gwen
Carr, Fiona
Doney, Alexander S. F.
Pearson, Ewan R.
Morris, Andrew D.
Johnson, Toby
McLaughlin, Megan M.
Williams, Rachel E.
Palmer, Colin N. A.
Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
title Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
title_full Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
title_fullStr Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
title_full_unstemmed Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
title_short Lp-PLA(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
title_sort lp-pla(2) activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447502/
https://www.ncbi.nlm.nih.gov/pubmed/29623345
http://dx.doi.org/10.1007/s00125-018-4601-7
work_keys_str_mv AT siddiquimoneezak lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT kennedygwen lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT carrfiona lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT doneyalexandersf lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT pearsonewanr lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT morrisandrewd lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT johnsontoby lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT mclaughlinmeganm lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT williamsrachele lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy
AT palmercolinna lppla2activityisassociatedwithincreasedriskofdiabeticretinopathyalongitudinaldiseaseprogressionstudy